ID Source | ID |
---|---|
PubMed CID | 7206 |
CHEMBL ID | 1446511 |
SCHEMBL ID | 1226040 |
MeSH ID | M0059188 |
Synonym |
---|
AC-12695 |
smr001224484 |
MLS002152860 , |
STL301520 |
acetic acid, (2,4-dichlorophenoxy)-, butyl ester |
butyl [(2,4-dichlorophenyl)oxy]acetate |
2,4-dichlorophenoxyacetic acid, n-butyl ester |
lironox |
nsc-409767 |
94-80-4 |
butyl dichlorophenoxyacetate |
2,4-dichlorophenoxyacetic acid n-butyl ester |
butyl 2,4-d |
esso herbicide 10 |
butyl ester 2,4-d |
(2, butyl ester |
butyl (2,4-dichlorophenoxy)acetate |
butyl ester of 2,4-d |
(2,4-dichlorophenoxy)acetic acid butyl ester |
2,4-dichlorophenoxyacetic acid butyl ester |
nsc409767 |
shell 40 |
acetic acid,4-dichlorophenoxy)-, butyl ester |
wln: gr cg do1vo4 |
2,4-d butyl ester |
butyl(2,4-dichlorophenoxy) acetate |
NCGC00090826-01 |
olin butyl ester d267 weed killer |
butapon |
amoco 2,4-d weed killer no. 6b |
general chemical 2,4-d 4-butyl ester weed killer |
(2,4-dichlorophenoxy)acetic acid, butyl ester |
parsons 2,4-d weed killer butyl ester |
miller's 4# ester |
floratox 428 4-pound 2,4-d ester weed killer |
n-butylester kyseliny 2,4-dichlorfenoxyoctove [czech] |
felco hv2 weed killer |
brn 2056085 |
chipman 2,4-d butyl ester 4e |
monsanto 2,4-d butyl ester |
t-h ded-weed me-9 |
general chemical 2,4-d 3.34 butyl ester weed killer |
fs ester 400 weed killer |
sure death 40% butyl ester type weedkiller |
2,4-dbe |
2,4-d-butyl [iso] |
unico 2,4-d ester weed killer |
component orange |
techne butyl ester weed killer no. 6 |
crop rider 2.67d |
caswell no. 315al |
chipman 2,4-d butyl ester 6e |
purple component |
de-pester ded-weed me-6 |
ai3-08686 |
mfa no. 4 weed killer |
chipman 2,4-d butyl ester 334e |
associated sales 4-pound 2,4-d ester weed killer |
rhodia 2,4-d butyl ester 6l |
hsdb 1633 |
hi-ester 2,4-d |
de-pester ded-weed me-4 |
the crop rider |
sure death no. 4 butyl ester weed killer |
weed-rhap b-6d |
butyl 400 |
t-h ded-weed me-6 |
miller's 6# ester |
epa pesticide chemical code 030056 |
mfa 40% butyl ester weed killer |
2,4-d-butyl |
general chemical 2,4-d 6.00 butyl ester weed killer |
nsc 409767 |
de-pester ded-weed me-5 |
olin butyl ester d4 weed killer |
abco w.k-67 2,4-d weed killer |
sure death no. 6 butyl ester weed killer |
techne butyl ester weed killer no. 4 |
weed-rhap b-4d |
lironox 326 |
butyl 2,4-dichlorophenoxyacetate |
de-pester ded-weed me-9 |
general chemical 2,4-d butyl ester weed killer |
weed-rhap b-2.67d |
einecs 202-364-8 |
line rider 4t |
felco butyl ester 600 2,4-d weed killer |
diamond shamrock butyl 4d |
barber's 2,4-d ester weed killer |
orange ii component |
barco weed killer (ester formulation) |
mfa no. 6 weed killer |
diamond shamrock butyl 6d weed killer |
green cross weed-no-more |
olin butyl ester d6 weed killer |
patterson's hi-test butyl ester 2,4-d weed killer |
techne 40% butyl ester type weed killer |
felco hv4 weed killer |
NCGC00090826-02 |
2,4-d n-butyl ester |
butyl 2-(2,4-dichlorophenoxy)acetate |
NCGC00090826-03 |
butyl 2,4-dichlorophenoxyacetate |
dtxsid5020443 , |
tox21_302757 |
cas-94-80-4 |
dtxcid10443 |
NCGC00256335-01 |
tox21_201237 |
NCGC00258789-01 |
AKOS005943535 |
6go3lvr34r , |
unii-6go3lvr34r |
n-butylester kyseliny 2,4-dichlorfenoxyoctove |
2,4-d 1-butyl ester |
2,4-d butyl ester [mi] |
2,4-dichlorophenoxyacetic acid, butyl ester |
UQMRAFJOBWOFNS-UHFFFAOYSA-N |
bdbm74250 |
2-(2,4-dichlorophenoxy)acetic acid butyl ester |
cid_7206 |
butyl 2-[2,4-bis(chloranyl)phenoxy]ethanoate |
Z54191175 |
2,4-dichlorophenoxyacetic butyl ester |
SCHEMBL1226040 |
W-100183 |
butyl 2-(2,4-dichlorophenoxy)ethanoate |
CHEMBL1446511 |
2,4-d 1-butyl ester, pestanal(r), analytical standard |
mfcd00126845 |
2,4-d-1-butyl ester |
2,4-d-1-butyl ester 100 microg/ml in cyclohexane |
FT-0710757 |
butyl 2,4-dichloro-phenoxyacetate |
2,4-d butylate |
Q27264880 |
EN300-112152 |
AS-76740 |
butyl2-(2,4-dichlorophenoxy)acetate |
CS-0012882 |
HY-B0867 |
Excerpt | Relevance | Reference |
---|---|---|
" B-lymphocyte mitogen responses were enhanced, though a linear dose-response relationship was not observed." | ( The effect of oral exposure to the n-butylester of 2,4-dichlorophenoxyacetic acid on the immune response in mice. Blakley, BR, 1986) | 0.27 |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 50.1187 | 0.0040 | 23.8416 | 100.0000 | AID485290 |
Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 79.4328 | 0.6310 | 35.7641 | 100.0000 | AID504339 |
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 17.6264 | 0.0072 | 15.7588 | 89.3584 | AID1224835; AID588342 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 19.5476 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521 |
AR protein | Homo sapiens (human) | Potency | 69.3576 | 0.0002 | 21.2231 | 8,912.5098 | AID1259243 |
apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 25.1189 | 0.7079 | 12.1943 | 39.8107 | AID720542 |
aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 39.8107 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 34.9355 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159553; AID1159555 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 69.3576 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 22.1349 | 0.3758 | 27.4851 | 61.6524 | AID743220 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 9.5686 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 35.4813 | 0.7079 | 36.9043 | 89.1251 | AID504333 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 6.9358 | 0.0016 | 28.0151 | 77.1139 | AID1224843 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 49.5539 | 0.0578 | 21.1097 | 61.2679 | AID1159526 |
chromobox protein homolog 1 | Homo sapiens (human) | Potency | 79.4328 | 0.0060 | 26.1688 | 89.1251 | AID540317 |
potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 50.1187 | 0.0178 | 9.6374 | 44.6684 | AID588834 |
lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 25.1189 | 0.0752 | 15.2253 | 39.8107 | AID485360 |
histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 31.6228 | 0.2512 | 15.8432 | 39.8107 | AID504327 |
Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 22.3872 | 3.9811 | 46.7448 | 112.2020 | AID720708 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
ORF73 | Human gammaherpesvirus 8 | EC50 (µMol) | 75.0000 | 0.0600 | 8.1346 | 32.1400 | AID435023 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
guanyl-nucleotide exchange factor activity | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
protein binding | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
cAMP binding | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
protein-macromolecule adaptor activity | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
small GTPase binding | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
cytosol | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
plasma membrane | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
membrane | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
hippocampal mossy fiber to CA3 synapse | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
plasma membrane | Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 14 (45.16) | 18.7374 |
1990's | 7 (22.58) | 18.2507 |
2000's | 3 (9.68) | 29.6817 |
2010's | 5 (16.13) | 24.3611 |
2020's | 2 (6.45) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (10.96) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 34 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |